Toronto – December 20, 2022 – The Canadian Nuclear Isotope Council (CNIC) is pleased to announce a partnership with ARC Clean Technology (ARC). As a member of the CNIC, ARC joins 76+ organizations and companies in Canada’s isotope community that work together to advance Canada’s role in the global supply chain for nuclear isotopes. ARC … Read more
Formed just six years ago, South West Exposures (SWE) is a company specializing in the design and fabrication of disruptive shielding technology for radiopharmaceutical products. As a Canadian-made company, SWE’s products are revolutionizing the manipulation and transportation of medical isotopes in Canada and globally. SWE comprises a small team of experts with broad experience in … Read more
Based in Owen Sound, Ontario, Stevcon Packaging & Logistics Ltd. (Stevcon) was established in 1997 and has become a truly Made-in-Canada Isotope Packaging and Testing Hub. With expertise in providing packaging solutions for industrial companies across Ontario and nationwide, Stevcon has successfully developed certified packaging for medical isotopes that meets nuclear and commercial standards. While … Read more
Toronto – November 10, 2022 – There is mounting concern in Canada and around the world that a global medical isotope shortage of Molybdenum-99 (Mo-99) is impacting patients. As a result, doctors will have to start rescheduling patients in need of diagnostic procedure and prioritizing urgent scans. In the interim, hospitals may also have to … Read more
Toronto – November 2, 2022 – AtomVie Global Radiopharma Inc. (AtomVie), a manufacturer and supplier of multiple finished-dose therapeutic radiopharmaceutical products, is the newest member of the Canadian Nuclear Isotope Council (CNIC). AtomVie has developed over 7 years of experience in the GMP manufacturing and global distribution of radiopharmaceuticals as the former CMO business unit … Read more
Toronto, Ontario – October 25, 2022 – Yesterday, the international partnership between Bruce Power, Isogen (a Kinectrics and Framatome company), and ITM Isotope Technologies Munich (ITM), announced the start of commercial production of lutetium-177. Lutetium-177 is a medical isotope used for targeted cancer therapies. The properties of the isotope allow it to bond with a … Read more
The week October 17th-21st, 2022 marked this year’s Nuclear Science Week (NSW), an international week-long celebration of all aspects of nuclear science. Held each October since 2010, NSW provides the opportunity to highlight innovation in nuclear and recognize the vital role it plays in the lives of people around the world. During NSW, many activities … Read more
Started in 1995, Promation quickly became an industry leader in automotive automation. Soon after, Promation leveraged its automation know-how and expanded into automation and tooling for nuclear applications for reactor maintenance, inspection, and refurbishment. Recently, Promation applied their knowledge of nuclear and automation to branch into the radiopharmaceutical industry. Promation now uses automation to developing … Read more
Company Highlights Growing Nuclear Medicine Product Portfolio and Future Opportunities in Therapeutic Radioisotopes (OTTAWA, ON – September 13, 2022) – BWX Technologies, Inc. (NYSE: BWXT) announced today that subsidiary BWXT Medical Ltd. has submitted a new drug application to the U.S. Food and Drug Administration (FDA) to request approval of its technetium-99m (Tc-99m) generator for … Read more
Toronto – August 16, 2022 – The Canadian Nuclear Isotope Council (CNIC) is proud to participate in a joint Industry Statement to the Tenth Review Conference of the Parties to the Treaty on the Non-Proliferation of Nuclear Weapons (NPT) alongside international and national industry associations covering a wide variety of nuclear applications. The NPT importantly … Read more